RNA Vaccines Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: R069C540BBD4EN
Market Monitor Global

Abstracts

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.

RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

This report contains market size and forecasts of RNA Vaccines in global, including the following market information:

Global RNA Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global RNA Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five RNA Vaccines companies in 2021 (%)

The global RNA Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Individualized Cancer Treatment MRNA Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of RNA Vaccines include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global RNA Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global RNA Vaccines Market Segment Percentages, by Type, 2021 (%)

• Individualized Cancer Treatment MRNA Vaccine
• Infectious Disease Treatment MRNA Vaccine
• Infection Prevention MRNA Vaccine

Global RNA Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global RNA Vaccines Market Segment Percentages, by Application, 2021 (%)

• Infectious Disease
• Cancer
• Other

Global RNA Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global RNA Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies RNA Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies RNA Vaccines revenues share in global market, 2021 (%)

Key companies RNA Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies RNA Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 RNA Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global RNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RNA VACCINES OVERALL MARKET SIZE

2.1 Global RNA Vaccines Market Size: 2021 VS 2028
2.2 Global RNA Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global RNA Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top RNA Vaccines Players in Global Market
3.2 Top Global RNA Vaccines Companies Ranked by Revenue
3.3 Global RNA Vaccines Revenue by Companies
3.4 Global RNA Vaccines Sales by Companies
3.5 Global RNA Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 RNA Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers RNA Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 RNA Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 RNA Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global RNA Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Individualized Cancer Treatment MRNA Vaccine
  4.1.3 Infectious Disease Treatment MRNA Vaccine
  4.1.4 Infection Prevention MRNA Vaccine
4.2 By Type - Global RNA Vaccines Revenue & Forecasts
  4.2.1 By Type - Global RNA Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global RNA Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global RNA Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global RNA Vaccines Sales & Forecasts
  4.3.1 By Type - Global RNA Vaccines Sales, 2017-2022
  4.3.2 By Type - Global RNA Vaccines Sales, 2023-2028
  4.3.3 By Type - Global RNA Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global RNA Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global RNA Vaccines Market Size, 2021 & 2028
  5.1.2 Infectious Disease
  5.1.3 Cancer
  5.1.4 Other
5.2 By Application - Global RNA Vaccines Revenue & Forecasts
  5.2.1 By Application - Global RNA Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global RNA Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global RNA Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global RNA Vaccines Sales & Forecasts
  5.3.1 By Application - Global RNA Vaccines Sales, 2017-2022
  5.3.2 By Application - Global RNA Vaccines Sales, 2023-2028
  5.3.3 By Application - Global RNA Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global RNA Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global RNA Vaccines Market Size, 2021 & 2028
6.2 By Region - Global RNA Vaccines Revenue & Forecasts
  6.2.1 By Region - Global RNA Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global RNA Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global RNA Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global RNA Vaccines Sales & Forecasts
  6.3.1 By Region - Global RNA Vaccines Sales, 2017-2022
  6.3.2 By Region - Global RNA Vaccines Sales, 2023-2028
  6.3.3 By Region - Global RNA Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America RNA Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America RNA Vaccines Sales, 2017-2028
  6.4.3 US RNA Vaccines Market Size, 2017-2028
  6.4.4 Canada RNA Vaccines Market Size, 2017-2028
  6.4.5 Mexico RNA Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe RNA Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe RNA Vaccines Sales, 2017-2028
  6.5.3 Germany RNA Vaccines Market Size, 2017-2028
  6.5.4 France RNA Vaccines Market Size, 2017-2028
  6.5.5 U.K. RNA Vaccines Market Size, 2017-2028
  6.5.6 Italy RNA Vaccines Market Size, 2017-2028
  6.5.7 Russia RNA Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries RNA Vaccines Market Size, 2017-2028
  6.5.9 Benelux RNA Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia RNA Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia RNA Vaccines Sales, 2017-2028
  6.6.3 China RNA Vaccines Market Size, 2017-2028
  6.6.4 Japan RNA Vaccines Market Size, 2017-2028
  6.6.5 South Korea RNA Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia RNA Vaccines Market Size, 2017-2028
  6.6.7 India RNA Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America RNA Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America RNA Vaccines Sales, 2017-2028
  6.7.3 Brazil RNA Vaccines Market Size, 2017-2028
  6.7.4 Argentina RNA Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa RNA Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa RNA Vaccines Sales, 2017-2028
  6.8.3 Turkey RNA Vaccines Market Size, 2017-2028
  6.8.4 Israel RNA Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia RNA Vaccines Market Size, 2017-2028
  6.8.6 UAE RNA Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Moderna Therapeutics
  7.1.1 Moderna Therapeutics Corporate Summary
  7.1.2 Moderna Therapeutics Business Overview
  7.1.3 Moderna Therapeutics RNA Vaccines Major Product Offerings
  7.1.4 Moderna Therapeutics RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Moderna Therapeutics Key News
7.2 CureVac
  7.2.1 CureVac Corporate Summary
  7.2.2 CureVac Business Overview
  7.2.3 CureVac RNA Vaccines Major Product Offerings
  7.2.4 CureVac RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 CureVac Key News
7.3 Translate Bio
  7.3.1 Translate Bio Corporate Summary
  7.3.2 Translate Bio Business Overview
  7.3.3 Translate Bio RNA Vaccines Major Product Offerings
  7.3.4 Translate Bio RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 Translate Bio Key News
7.4 BioNTech
  7.4.1 BioNTech Corporate Summary
  7.4.2 BioNTech Business Overview
  7.4.3 BioNTech RNA Vaccines Major Product Offerings
  7.4.4 BioNTech RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 BioNTech Key News
7.5 Sangamo Therapeutics
  7.5.1 Sangamo Therapeutics Corporate Summary
  7.5.2 Sangamo Therapeutics Business Overview
  7.5.3 Sangamo Therapeutics RNA Vaccines Major Product Offerings
  7.5.4 Sangamo Therapeutics RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Sangamo Therapeutics Key News
7.6 Argos Therapeutics
  7.6.1 Argos Therapeutics Corporate Summary
  7.6.2 Argos Therapeutics Business Overview
  7.6.3 Argos Therapeutics RNA Vaccines Major Product Offerings
  7.6.4 Argos Therapeutics RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.6.5 Argos Therapeutics Key News
7.7 In-Cell-Art
  7.7.1 In-Cell-Art Corporate Summary
  7.7.2 In-Cell-Art Business Overview
  7.7.3 In-Cell-Art RNA Vaccines Major Product Offerings
  7.7.4 In-Cell-Art RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.7.5 In-Cell-Art Key News
7.8 eTheRNA
  7.8.1 eTheRNA Corporate Summary
  7.8.2 eTheRNA Business Overview
  7.8.3 eTheRNA RNA Vaccines Major Product Offerings
  7.8.4 eTheRNA RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.8.5 eTheRNA Key News
7.9 Ethris
  7.9.1 Ethris Corporate Summary
  7.9.2 Ethris Business Overview
  7.9.3 Ethris RNA Vaccines Major Product Offerings
  7.9.4 Ethris RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.9.5 Ethris Key News
7.10 Tiba Biotechnology
  7.10.1 Tiba Biotechnology Corporate Summary
  7.10.2 Tiba Biotechnology Business Overview
  7.10.3 Tiba Biotechnology RNA Vaccines Major Product Offerings
  7.10.4 Tiba Biotechnology RNA Vaccines Sales and Revenue in Global (2017-2022)
  7.10.5 Tiba Biotechnology Key News

8 GLOBAL RNA VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global RNA Vaccines Production Capacity, 2017-2028
8.2 RNA Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RNA VACCINES SUPPLY CHAIN ANALYSIS

10.1 RNA Vaccines Industry Value Chain
10.2 RNA Vaccines Upstream Market
10.3 RNA Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 RNA Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of RNA Vaccines in Global Market
Table 2. Top RNA Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global RNA Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global RNA Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global RNA Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global RNA Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers RNA Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers RNA Vaccines Product Type
Table 9. List of Global Tier 1 RNA Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global RNA Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global RNA Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global RNA Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global RNA Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global RNA Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global RNA Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global RNA Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global RNA Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global RNA Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global RNA Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global RNA Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America RNA Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America RNA Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe RNA Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe RNA Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia RNA Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia RNA Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America RNA Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America RNA Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa RNA Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa RNA Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa RNA Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa RNA Vaccines Sales, (K Doses), 2023-2028
Table 46. Moderna Therapeutics Corporate Summary
Table 47. Moderna Therapeutics RNA Vaccines Product Offerings
Table 48. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. CureVac Corporate Summary
Table 50. CureVac RNA Vaccines Product Offerings
Table 51. CureVac RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Translate Bio Corporate Summary
Table 53. Translate Bio RNA Vaccines Product Offerings
Table 54. Translate Bio RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. BioNTech Corporate Summary
Table 56. BioNTech RNA Vaccines Product Offerings
Table 57. BioNTech RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Sangamo Therapeutics Corporate Summary
Table 59. Sangamo Therapeutics RNA Vaccines Product Offerings
Table 60. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Argos Therapeutics Corporate Summary
Table 62. Argos Therapeutics RNA Vaccines Product Offerings
Table 63. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. In-Cell-Art Corporate Summary
Table 65. In-Cell-Art RNA Vaccines Product Offerings
Table 66. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. eTheRNA Corporate Summary
Table 68. eTheRNA RNA Vaccines Product Offerings
Table 69. eTheRNA RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Ethris Corporate Summary
Table 71. Ethris RNA Vaccines Product Offerings
Table 72. Ethris RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Tiba Biotechnology Corporate Summary
Table 74. Tiba Biotechnology RNA Vaccines Product Offerings
Table 75. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. RNA Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 77. Global RNA Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global RNA Vaccines Production by Region, 2017-2022 (K Doses)
Table 79. Global RNA Vaccines Production by Region, 2023-2028 (K Doses)
Table 80. RNA Vaccines Market Opportunities & Trends in Global Market
Table 81. RNA Vaccines Market Drivers in Global Market
Table 82. RNA Vaccines Market Restraints in Global Market
Table 83. RNA Vaccines Raw Materials
Table 84. RNA Vaccines Raw Materials Suppliers in Global Market
Table 85. Typical RNA Vaccines Downstream
Table 86. RNA Vaccines Downstream Clients in Global Market
Table 87. RNA Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. RNA Vaccines Segment by Type
Figure 2. RNA Vaccines Segment by Application
Figure 3. Global RNA Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. RNA Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by RNA Vaccines Revenue in 2021
Figure 9. By Type - Global RNA Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global RNA Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global RNA Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global RNA Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global RNA Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global RNA Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global RNA Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global RNA Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America RNA Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America RNA Vaccines Sales Market Share, 2017-2028
Figure 19. US RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe RNA Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe RNA Vaccines Sales Market Share, 2017-2028
Figure 24. Germany RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia RNA Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia RNA Vaccines Sales Market Share, 2017-2028
Figure 33. China RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America RNA Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America RNA Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa RNA Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa RNA Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE RNA Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global RNA Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production RNA Vaccines by Region, 2021 VS 2028
Figure 50. RNA Vaccines Industry Value Chain
Figure 51. Marketing Channels